Health Notices




14 JANUARY NEW ZEALAND GAZETTE 57

executed on the 21st day of December 1998. Copies of the
supplementary integration agreements are available for
inspection without charge by any member of the public
at the district office of the Ministry of Education,
39–45 College Hill, Ponsonby, Auckland.

Dated at Wellington this 21st day of December 1998.

KATHY PHILLIPS. Senior Manager, National Operations.
go183


Health

Medicines Act 1981

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Factor IX 500IU and water for injection 10 mL, as diluent Injection, powder (vial) with diluent (ampoule) CSL Limited, Bioplasma Division, Broadmeadows, Victoria, Australia; Diluent: Pharmacia & Upjohn (Perth) Pty Limited, Bentley, Western Australia, Australia MonoFix-VF

Note: This consent is valid for 2 years from the date of publication of this notice.

Dated this 22nd day of December 1998.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go268


Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Loperamide hydrochloride 2 mg Tablet Apotex Inc., Weston, Ontario, Canada Apo-Loperamide
Bifonazole 1% w/w Cream, topical Bayer AG., Leverkusen, Germany and Bayer Australia Limited, Health Care Operations Centre, Mulgrave, Victoria, Australia Canesten Once Daily Bifonazole
Desonide 0.05% w/w Ointment, topical Laboratoires Galderma, Zone d’activite de Montdesir, Alby Sur Cheran, France Desowen
Desonide 0.05% w/w Cream, topical Laboratoires Galderma, Zone d’activite de Montdesir, Alby Sur Cheran, France Desowen
Desonide 0.05% w/w Lotion, skin Laboratoires Galderma, Zone d’activite de Montdesir, Alby Sur Cheran, France Desowen
Salicylic acid 27% w/w Gel, topical Stiefel Laboratories (Ireland) Limited, Sligo, Ireland Duofilm
Codeine phosphate (anhydrous) 12.8 mg, ibuprofen 200 mg Tablet The Boots Company Plc., Beeston, Nottingham, United Kingdom Nurofen Plus
Camphor 1.24% w/w, menthol 5.71% w/w, methyl salicylate 6.29% w/w Transdermal patch Hisamitsu Pharmaceutical Co Inc., Tosu, Saga, Japan Salonpas
Betahistine hydrochloride 4 mg, 8 mg, 16 mg Tablets Solvay Duphar BV., Olst, The Netherlands Serc
Carmellose sodium 2.5 mg/mL Drops, eye, solution Ciba Vision Sterile Manufacturing, Mississauga, Ontario, Canada Thera Tears

Dated this 11th day of January 1999.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go344


Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1999, No 1


NZLII PDF NZ Gazette 1999, No 1





✨ LLM interpretation of page content

🏥 Provisional Consent to Distribution of New Medicine

🏥 Health & Social Welfare
22 December 1998
Medicines Act 1981, Provisional Consent, New Medicine, Factor IX, MonoFix-VF
  • G. R. Boyd, Chief Advisor, Regulation and Safety

🏥 Consent to Distribution of New Medicines

🏥 Health & Social Welfare
11 January 1999
Medicines Act 1981, New Medicines, Loperamide, Bifonazole, Desonide, Salicylic Acid, Codeine Phosphate, Ibuprofen, Camphor, Menthol, Methyl Salicylate, Betahistine Hydrochloride, Carmellose Sodium
  • G. R. Boyd, Chief Advisor, Regulation and Safety

🏥 Consent to Distribution of Changed Medicines

🏥 Health & Social Welfare
Medicines Act 1981, Changed Medicines, Section 24(5)